Advertisement
Screener

Nexalin Technology, Inc. (NXL) Labor and Related Expense

2.8 / 5 stars · 68/120 Roast Me

Nexalin Technology, Inc. Labor and Related Expense

Nexalin Technology, Inc. (NXL) reported Labor and Related Expense of $501.72 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:LaborAndRelatedExpense · last filed 2026-08-12

  • Nexalin Technology, Inc. labor and related expense for the quarter ending 2026-06-30 was $501.72K, a 35.45% increase year-over-year.
  • Nexalin Technology, Inc. labor and related expense for the quarter ending 2026-03-31 was $498.56K, a 48.67% increase year-over-year.
  • Nexalin Technology, Inc. labor and related expense for the quarter ending 2025-12-31 was $725.44K, a 26.82% increase year-over-year.
  • Nexalin Technology, Inc. labor and related expense for the quarter ending 2025-09-30 was $448.08K, a 52.32% increase year-over-year.
  • Nexalin Technology, Inc. labor and related expense for fiscal 2025 was $1.88M, a 25.28% increase from fiscal 2024.
  • Nexalin Technology, Inc. labor and related expense for fiscal 2024 was $1.50M, a 8.08% increase from fiscal 2023.
  • Nexalin Technology, Inc. labor and related expense for fiscal 2023 was $1.39M, a 99.96% increase from fiscal 2022.
  • Nexalin Technology, Inc. labor and related expense for fiscal 2022 was $694.11K, a 203.45% increase from fiscal 2021.
Period endLabor and Related Expense 3 monthLabor and Related Expense 6 monthLabor and Related Expense 9 monthLabor and Related Expense 12 month
2026-06-30$501.72K
10-Q · filed 2026-08-12
$1.00M
10-Q · filed 2026-08-12
$1.73M
derived: sum of 3 quarters · filed 2026-08-12
$2.17M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$498.56K
10-Q · filed 2026-05-08
$1.22M
derived: sum of 2 quarters · filed 2026-05-08
$1.67M
derived: sum of 3 quarters · filed 2026-05-08
$2.04M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$725.44K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$1.17M
derived: sum of 2 quarters · filed 2026-03-25
$1.54M
derived: sum of 3 quarters · filed 2026-08-12
$1.88M
10-K · filed 2026-03-25
2025-09-30$448.08K
10-Q · filed 2025-11-14
$818.49K
derived: sum of 2 quarters · filed 2026-08-12
$1.15M
10-Q · filed 2025-11-14
$1.73M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$370.40K
10-Q · filed 2026-08-12
$705.76K
10-Q · filed 2026-08-12
$1.28M
derived: sum of 3 quarters · filed 2026-08-12
$1.57M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$335.36K
10-Q · filed 2026-05-08
$907.38K
derived: sum of 2 quarters · filed 2026-05-08
$1.20M
derived: sum of 3 quarters · filed 2026-05-08
$1.51M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$572.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$866.19K
derived: sum of 2 quarters · filed 2026-03-25
$1.17M
derived: sum of 3 quarters · filed 2026-03-25
$1.50M
10-K · filed 2026-03-25
2024-09-30$294.18K
10-Q · filed 2025-11-14
$601.65K
derived: sum of 2 quarters · filed 2025-11-14
$928.07K
10-Q · filed 2025-11-14
$1.35M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$307.48K
10-Q · filed 2025-08-06
$633.90K
10-Q · filed 2025-08-06
$1.06M
derived: sum of 3 quarters · filed 2025-09-23
$1.42M
derived: sum of 4 quarters · filed 2025-09-23
2024-03-31$326.42K
10-Q · filed 2025-05-13
$748.35K
derived: sum of 2 quarters · filed 2025-09-23
$1.11M
derived: sum of 3 quarters · filed 2025-09-23
$1.42M
derived: sum of 4 quarters · filed 2025-09-23
2023-12-31$421.93K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-23
$785.26K
derived: sum of 2 quarters · filed 2025-09-23
$1.09M
derived: sum of 3 quarters · filed 2025-09-23
$1.39M
10-K/A · filed 2025-09-23
2023-09-30$363.33K
10-Q · filed 2024-11-08
$666.66K
derived: sum of 2 quarters · filed 2024-11-08
$965.99K
10-Q · filed 2024-11-08
$1.19M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30$303.33K
10-Q · filed 2024-08-08
$602.66K
10-Q · filed 2024-08-08
$826.77K
derived: sum of 3 quarters · filed 2024-08-08
$990.91K
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$299.32K
10-Q · filed 2024-05-10
$523.43K
derived: sum of 2 quarters · filed 2024-05-10
$687.58K
derived: sum of 3 quarters · filed 2024-05-10
$854.84K
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$224.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
$388.25K
derived: sum of 2 quarters · filed 2024-03-27
$555.51K
derived: sum of 3 quarters · filed 2024-03-27
$694.11K
10-K · filed 2024-03-27
2022-09-30$164.14K
10-Q · filed 2023-11-13
$331.40K
derived: sum of 2 quarters · filed 2023-11-13
$470.00K
10-Q · filed 2023-11-13
$534.55K
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$167.26K
10-Q · filed 2023-08-10
$305.85K
10-Q · filed 2023-08-10
$370.40K
derived: sum of 3 quarters · filed 2023-08-10
$438.07K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$138.59K
10-Q · filed 2023-05-10
$203.15K
derived: sum of 2 quarters · filed 2023-05-10
$270.81K
derived: sum of 3 quarters · filed 2023-05-10
2021-12-31$64.55K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27
$132.21K
derived: sum of 2 quarters · filed 2023-03-27
$228.74K
10-K · filed 2023-03-27
2021-09-30$67.66K
10-Q · filed 2022-11-10
$164.19K
10-Q · filed 2022-11-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuraxis, INC (NRXS)United States$0.097B
Streamex Corp. (STEX)United States$0.089B-0.19
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
EDAP TMS SA (FOCL)$0.171B
IRIDEX CORP (IRIX)United States$0.011B